Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008–20. https://doi.org/10.1016/S0140-6736(20)30974-0.
2. Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 1.2022, NCCN Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network. Available at: https://www.nccn.org/guidelines/guidlines-detail?category=1&id=1455. Accessed 11 April 2022.
3. Khorana AA, Mangu PB, Berlin J, et al. Potentially curable pancreatic cancer: American Society of clinical oncology clinical practice guideline. J Clin Oncol. 2016;34(21):2541–56. https://doi.org/10.1200/JCO.2016.67.5553.
4. van Dam JL, Janssen QP, Besselink MG, et al. Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomised controlled trials. Eur J Cancer. 2022;160:140–9. https://doi.org/10.1016/j.ejca.2021.10.023.
5. Seufferlein T, Uhl W, Kornmann M, et al. Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group. Ann Oncol. 2023;34(1):91–100. https://doi.org/10.1016/j.annonc.2022.09.161.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献